Time evolution of patient outcomes for a range of neutrophil (<i>N</i>) and cortisol (<i>C</i>) initial conditions for model (1). by Manuel Mai (497861)

A partially porous sheath with a moderate length <i>L</i>_<i>p</i> limits the decrease of VEGF concentration while still increasing cell density and oxygen concentration... by Rachel Coy (4027016)

Multicenter Phase 2 Trial of Sirolimus for Tuberous Sclerosis: Kidney Angiomyolipomas and Other Tumors Regress and VEGF- D Levels Decrease by Sandra L. Dabora (206838)

“…Kidney angiomyolipomas regrew when sirolimus was discontinued but responses tended to persist if treatment was continued after week 52. We observed regression of brain tumors (SEGAs) in 7/11 cases (26% mean decrease in diameter), regression of liver angiomyolipomas in 4/5 cases (32.1% mean decrease in longest diameter), subjective improvement in facial angiofibromas in 57%, and stable lung function in women with TSC/LAM (n = 15). …”

Patient characteristics and treatment history (N = 33, all TNBCs^†). by Ting-Fang He (5210948)

FEA results meshes for 5N force. by Nathan L. Wright (18389458)

Beta-catenin signaling is decreased in intermediate progenitor cells. by Christopher A. Mutch (243132)

“…<p>(<b>A</b>) Cortex from E14.5 Axin2-d2EGFP transgenic mice stained for GFP (green), Tbr2 (red), and DNA (blue). …”

GSK343 decreased viability and proliferation in human neuroblastoma PDX cells. by Laura V. Bownes (10276762)

“…Treatment with GSK343 resulted in significantly decreased migration. (D) After 24 hours of treatment with increasing concentrations of GSK343 (0, 5, 10 μM), COA3 and COA6 cells (4.0 × 10⁴) were plated in Transwell^® inserts and allowed to invade for 1 week through a Matrigel^™ layer. …”

The MTT assay to determine decreases in residual cell viability in SK-N-BE2 and IMR-32 cells. by Nishant Mohan (474067)

“…Significant difference between CTL and a treatment was indicated by *<i>P</i><0.05 while significant difference between single treatment and double treatment was indicated by #<i>P</i><0.05.…”

Reduced RabGEF1 expression decreases NGF-induced TrkA phosphorylation but not TrkA internalization. by See-Ying Tam (828866)

Stabilization of Hif-1α at early stages of infection leads to a decrease in bacterial burden. by Philip M. Elks (324793)

“…(E) Bacterial pixel counts of RNA injected larvae at 4 dpi. Dominant active <i>hif-1αb</i> (DA1) significantly decreased bacterial burden in infected larvae compared to both phenol red injected controls (PR) and dominant negative <i>hif-1αb</i> (DN1). …”

Decreasing trends in HbA1c are visible when using the average HbA1c for each dataset for T1Ds, but not T2Ds. by Hans F. Dias (14486401)

Decrease of mitochondrial membrane potential by silvestrol. by Takayuki Kogure (235048)

SARS-CoV-2 decreases excitatory synapses, while influenza A does not induce cell death in BCO. by Pinar Mesci (14053895)

Baseline characteristics of participants (<i>n </i>= 1480). by Somayeh Momenyan (10111603)

DHPE but not compounds 98, 48, 26 nor locostatin decreases RKIP interactions with Raf-1 and PKC. by Anne N. Shemon (249363)

<i>Mdk</i>-deficient mice aged 9 months displayed increased trabecular number and decreased cortical thickness in the femur. by Melanie Haffner-Luntzer (504724)

Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies. by Elizabeth S. Munroe (21568166)

The decrease of <i>USP28</i> protein levels induced by Ni ions or hypoxia contributed to c-Myc degradation in A549 cells. by Qin Li (36669)

DualAG decreased TG synthesis in DIO mice. by Vijay R. More (4532392)

3-AT selectively decreased peroxisomal matrix protein abundance in Raw264.7 cells. by Yizhu Mu (10169657)